Articles
Volume 7 Supplement 1
Proceedings of the 2011 International Conference on Molecular Neurodegeneration
Meeting abstracts
2011 International Conference on Molecular Neurodegeneration
Shanghai, China
22-24 September 2011
Edited by Hui Zheng, Bob Vassar, Caroline Stetler and Chunjiu Zhong
|
Discovery of nitric oxide and cyclic GMP in cell signaling and their role in drug development Ferid Murad Molecular Neurodegeneration 2012, 7(Suppl 1):L1 (7 February 2012) |
|
Ping Gong, Jelita Roseman, Kulandaivelu S Vetrivel, Vytautas P Bindokas, Lois A Zitzow, Satyabrata Kar, Angèle T Parent, Gopal Thinakaran Molecular Neurodegeneration 2012, 7(Suppl 1):L2 (7 February 2012) |
|
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease Robert Vassar Molecular Neurodegeneration 2012, 7(Suppl 1):L3 (7 February 2012) |
|
Gamma-secretase: from pathogenesis to therapeutics Yueming Li Molecular Neurodegeneration 2012, 7(Suppl 1):L4 (7 February 2012) |
|
Structure-function relationship of γ-secretase Taisuke Tomita Molecular Neurodegeneration 2012, 7(Suppl 1):L5 (7 February 2012) |
|
Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP Wim Annaert Molecular Neurodegeneration 2012, 7(Suppl 1):L6 (7 February 2012) |
|
Deciphering the role of APP in synaptic function Hui Zheng Molecular Neurodegeneration 2012, 7(Suppl 1):L7 (7 February 2012) |
|
Presenilins in Alzheimer’s disease and frontotemporal dementia Jie Shen Molecular Neurodegeneration 2012, 7(Suppl 1):L8 (7 February 2012) |
|
Robert Tamayev, Shuji Matsuda, Luciano D’Adamio Molecular Neurodegeneration 2012, 7(Suppl 1):L9 (7 February 2012) |
|
ApoE and apoE receptors in brain lipid metabolism and AD Guojun Bu Molecular Neurodegeneration 2012, 7(Suppl 1):L10 (7 February 2012) |
|
ApoER2 trafficking, processing and signaling and its participation in neurodegeneration María-Paz Marzolo Molecular Neurodegeneration 2012, 7(Suppl 1):L11 (7 February 2012) |
|
Elucidating the mechanisms underlying Alzheimer's disease-associated genetic polymorphisms Steven Estus Molecular Neurodegeneration 2012, 7(Suppl 1):L12 (7 February 2012) |
|
Molecular pathways to Parkinson’s disease Ming Guo Molecular Neurodegeneration 2012, 7(Suppl 1):L13 (7 February 2012) |
|
Does axonopathy play a role in Parkinson's disease? Karen L O’Malley, Jo Ann Antenor-Dorsey, Jeong Sook Kim-Han Molecular Neurodegeneration 2012, 7(Suppl 1):L14 (7 February 2012) |
|
Molecular Neurodegeneration 2012, 7(Suppl 1):L15 (7 February 2012) |
|
The role of DJ-1 in anti-apoptosis Haigang Ren, Kai Fu, Jun Fan, Guanghui Wang Molecular Neurodegeneration 2012, 7(Suppl 1):L16 (7 February 2012) |
|
Neuropathology of transgenic HD animal models Xiaojiang Li, Shihua Li Molecular Neurodegeneration 2012, 7(Suppl 1):L17 (7 February 2012) |
|
Novel circuitry and molecular pathogenic mechanisms in Huntington's disease X William Yang Molecular Neurodegeneration 2012, 7(Suppl 1):L18 (7 February 2012) |
|
Mechanisms and models of TDP-43 proteinopathies Leonard Petrucelli Molecular Neurodegeneration 2012, 7(Suppl 1):L19 (7 February 2012) |
|
George M Martin Molecular Neurodegeneration 2012, 7(Suppl 1):L20 (7 February 2012) |

